CoreCap Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

CoreCap Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,193	Closed	-$13K	–	2375
2021 Q4	$13K	Buy	+4,193	New	+$14.1K	﹤0.01%	1478

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

CoreCap Advisors's BDSI Position: Q1 2022 in Review

CoreCap Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 4,193 shares — an estimated $13K sold.

CoreCap Advisors first reported a position in BDSI in Q4 2021 and held it in 1 quarter. The position peaked at $13K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

CoreCap Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
CoreCap Advisors sold 4,193 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $13K.
CoreCap Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2021 and held it in 1 quarter.
CoreCap Advisors's BioDelivery Sciences International, Inc. position peaked at $13K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on CoreCap Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.